CIK 0001285819
- Non-accelerated filer
- Smaller reporting company
OMEROS CORP
Sign in to watch- Ticker
- OMER
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 911663741
- Phone
- +1 206-676-5000
- Business address
- 201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 3,000 shares at $10.21 ($30,642)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chairman, CEO & President sold 306,124 shares at an average $10.66 ($3,263,485)
- 4 Open-market sale Chairman, CEO & President sold 306,120 shares at an average $11.58 ($3,546,135)
- 4 Exercise or conversion VP Patent and General Counsel acquired 3,004 shares (option exercise)
- 4 Open-market sale VP Patent and General Counsel sold 16,000 shares at $10.91 ($174,578)
- 4 Open-market sale VP Patent and General Counsel sold 15,900 shares at $11.56 ($183,826)
- 4 Open-market sale Director sold 3,000 shares at $11.52 ($34,557)
- 4 Open-market sale VP Patent and General Counsel sold 15,900 shares at $11.50 ($182,804)
- 4 Open-market sale VP Patent and General Counsel sold 15,900 shares at $11.42 ($181,503)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale VP Patent and General Counsel sold 15,900 shares at $9.94 ($158,057)
Page 9 of 15 · 295 filings